University of California, San Francisco |
In 2021, the National Clinician Consultation Center (NCCC) developed a novel PrEP champion preceptorship to increase pharmacists’, advanced practice registered nurses’, and registered nurses’ comfort and clinical capacity concerning PrEP delivery. This paper describes the need for this specialized training, the development process, and the training’s impact on learners’ knowledge and capabilities to enhance PrEP […]
Archive | News & Updates
National HIV Testing Day – June 27th
In support of National HIV Testing Day (June 27), the NCCC would like to encourage all health care providers, regardless of practice setting or location, to offer HIV testing to adolescents and adults, including pregnant persons. For providers interested in more information, this brief review of HIV care includes details on screening and testing as […]
National PEPline Recommendations on Percutaneous Exposures to SARS-CoV-2 in Occupational Settings
QUESTION Is there a risk of percutaneous SARS-CoV-2 transmission via blood following a needlestick or other sharps injury involving a source person who has or might have SARS-CoV-2, the virus that causes COVID-19? RESPONSE SARS-CoV-2 is not considered a blood-borne pathogen. SARS-CoV-2 is a respiratory virus; respiratory viruses are not known to be transmitted by […]
Information about COVID-19 for Clinicians
Because of the rapidly-changing understanding of COVID-19, here are some of the key links to guidances for clinicians: Interim Guidance for COVID-19 and Persons with HIV Open Link | From AIDSinfo (DHHS) HRSA HIV/AIDS Bureau (HAB) Frequently Asked Questions Open Link | From Health Resources & Services Administration (HRSA) Information for Healthcare Professionals Open Link […]
CCC Update to FDA Notice: Dolutegravir and Post-Exposure Prophylaxis (PEP)
**PLEASE NOTE: This statement is now outdated. We will provide updates when additional data is available. In the meantime, please reference the HHS Perinatal Guidelines for more information on dolutegravir in pregnancy and pre-conception: https://aidsinfo.nih.gov/guidelines/html/3/perinatal-guidelines/0** On May 30, 2018 the HHS Antiretroviral Guidelines Panels issued recommendations on the use of dolutegravir for treatment of adults and […]
CCC Response to FDA Notice: Dolutegravir and Post-Exposure Prophylaxis (PEP)
The U.S. Food and Drug Administration (FDA) alerted the public on 5/18/18 that serious cases of neural tube birth defects have been reported in babies born to women living with HIV who were treated with dolutegravir at the time of becoming pregnant or early in the first trimester (https://fda.gov/Drugs/DrugSafety/ucm608112.htm). Until more information is available, we […]
National HIV Testing Day 2017: Test Your Way. Do It Today!
HIV Testing Is the First Step to Care National HIV Testing Day (NHTD) is an annual campaign encouraging people of all ages to get tested for HIV and know their status. In the United States, an estimated 1.1 million people are living with HIV, and 1 in 7 of them is unaware of their diagnosis […]
PEPline Crowdfunding Update
PEPline Crowdfunding Update Despite the invaluable service the PEPline provides, federal funding has not been able to keep up with the increased demand for expert consultations. For those who need the service, we fear this will result in less-than-optimal service, as it is incredibly important to receive timely expert guidance in order to prevent HIV […]
National Asian & Pacific Islander HIV/AIDS Awareness Day 2017
May 19th is the 13th annual National Asian & Pacific Islander HIV/AIDS Awareness Day, originally founded by the Banyan Tree Project with support from the Centers for Disease Control and Prevention (CDC) to end stigma, prevent HIV, and help A&PIs living with HIV. This year’s campaign slogan is “Saving face can’t make you safe. Talk […]
Hepatitis Awareness Month 2017
In the United States, over 4.4 million people are living with chronic viral hepatitis (CDC). Viral hepatitis can lead to increased risk for various health conditions, such as chronic liver disease and cancer, and currently causes more than 200,000 deaths in the United States (NASEM). Chronic liver disease/cirrhosis is the 4th most common cause of death […]